Tag: capecitabine

1. Progression-free survival was extended by the use capecitabine as compared to active monitoring, but at the expense of increased toxicity. There was no difference in overall survival between treatment arms. 2. Quality of life scores were similar between the two treatment arms. Evidence Rating Level: 1 (Excellent) Study Rundown: Current standards...
1. Adjuvant capecitabine resulted in fewer instances of disease recurrence and death compared to standard therapy. 2. Overall and failure-free survival at 3 years was significantly greater in the capecitabine group. Evidence Rating Level: 1 (Excellent) Study Rundown: Nasopharyngeal carcinoma is a form of invasive head and neck cancer with a favorable...